2006
DOI: 10.1016/j.cellimm.2007.01.001
|View full text |Cite
|
Sign up to set email alerts
|

CD4+ T cell migration into the cornea is reduced in CXCL9 deficient but not CXCL10 deficient mice following herpes simplex virus type 1 infection

Abstract: The role of CXCL9 and CXCL10 in the ocular immune response to herpes simplex virus type 1 (HSV-1) infection was investigated using mice deficient in either CXCL9 or CXCL10. CXCL10 but not CXCL9 deficient mice showed an increase in sensitivity to ocular virus infection as measured by an elevation in virus titer recovered in the tear film and corneal tissue. The increase in virus was associated with an increase in the expression of the chemokine CCL2 but no significant change in the infiltration of CD4 + T cells… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

6
38
1

Year Published

2008
2008
2019
2019

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 48 publications
(45 citation statements)
references
References 46 publications
6
38
1
Order By: Relevance
“…The preferential contribution of one CXCR3 ligand to disease pathology has been seen in other inflammatory models of disease, such as CXCL10 in mouse hepatitis virus and Dengue virus encephalitis 29,30 and CXCL9 in herpes simplex virus-1 ocular infection and cytomegalovirus infection. 31,32 Regardless of the exact mechanisms, our findings indicate that selective blockade of CXCL9 and CXCR3 is a potential therapeutic strategy to combat immune-mediated renal diseases.…”
Section: Discussionmentioning
confidence: 91%
“…The preferential contribution of one CXCR3 ligand to disease pathology has been seen in other inflammatory models of disease, such as CXCL10 in mouse hepatitis virus and Dengue virus encephalitis 29,30 and CXCL9 in herpes simplex virus-1 ocular infection and cytomegalovirus infection. 31,32 Regardless of the exact mechanisms, our findings indicate that selective blockade of CXCL9 and CXCR3 is a potential therapeutic strategy to combat immune-mediated renal diseases.…”
Section: Discussionmentioning
confidence: 91%
“…Results from many mouse models of herpesvirus infection and immunity have yielded tremendous insights into the protective and immunopathological mechanisms during primary acute infection (46)(47)(48)(49)(50)(51)(52). However, the extrapolation of results from mouse primary herpetic disease to human recurrent herpetic diseases, such as recurrent herpetic stromal keratitis (rHSK), is yet to be proven.…”
Section: Discussionmentioning
confidence: 99%
“…The preferential contribution of a single CXCR3 chemokine to disease pathology has been reported in other inflammatory models, such as IP-10 in mouse models of hepatitis virus or dengue virus infection 26,27) . MIG has been shown to independently contribute to the pathological response to herpes simplex virus type 1 or cytomegalovirus infection and also in human immunemediated kidney diseases [28][29][30] . Further studies regarding the precise biological role of MIG in the pathogenesis of atherosclerosis are therefore needed.…”
Section: Discussionmentioning
confidence: 99%